Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.62
0.27 (6.21%)
At close: Aug 15, 2025, 2:59 PM
Monte Rosa Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12.29M | 46.88M | 13.44M | -23.86M | -30.31M | -31.97M | -33.25M | -34.88M | -35.18M | -32.04M | -30.78M | -27.32M | -26.47M | -23.93M | -23.44M | -19.84M | -18.41M | -12.28M |
Depreciation & Amortization | 2.13M | 2.05M | 2.06M | 2.1M | 2.06M | 1.9M | 1.85M | 1.83M | 1.39M | 1.15M | 1.07M | 1.03M | 889K | 753K | 809K | 582K | 467K | 274K |
Stock-Based Compensation | 4.89M | 5.3M | 4.47M | 4.28M | 4.5M | 4.87M | 4.07M | 4.47M | 4.15M | 3.97M | 3.33M | 3.21M | 2.87M | 2.25M | 1.86M | 2.07M | 1.02M | 252K |
Other Working Capital | -26.64M | -86.53M | 95.92M | 9.29M | 6.01M | -7.82M | 51.94M | 3.31M | 6.75M | 4.34M | 1.92M | -382K | 1.57M | -4.5M | 1.86M | 3.63M | 3.63M | -2.12M |
Other Non-Cash Items | -737K | -1.09M | -696K | -19.34M | -1.09M | -69K | 1.26M | -497K | -1.44M | -1.14M | 352K | 1.21M | 994K | 209K | 4K | 13K | 2.24M | 960K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -28.71M | -98.64M | 109.65M | 15.82M | -2.92M | -12.9M | 57.7M | 4.37M | 5.75M | 4.64M | 2.07M | 1.27M | 1.21M | -6.68M | 6.6M | -625K | 3.34M | -3.02M |
Operating Cash Flow | -34.72M | -45.49M | 128.92M | -20.99M | -27.77M | -38.16M | 29.63M | -24.71M | -25.32M | -23.41M | -23.96M | -20.6M | -20.5M | -27.4M | -14.17M | -17.79M | -13.58M | -13.81M |
Capital Expenditures | -1.7M | -1.59M | -183K | -399K | -2.02M | -1.38M | -1.69M | -1.66M | -6.51M | -9.18M | -7.27M | -1.4M | -2.55M | -1.69M | -3.06M | -1.75M | -2.7M | -2.22M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -15.99K | -37.29K | 62K | 131K | 46.67K | -16K | 11.7K | 125K | 12K | 67K | n/a | n/a |
Purchase of Investments | -19.03M | -138.01M | -67.96M | -32.37M | -73.96M | -56.07M | -27.51M | -7.81M | -62K | -67.82M | -94.37M | -59.4M | -51.7M | -178.96M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 46.05M | 39.37M | 37.25M | 70.52M | 14.82M | 67.31M | 43.5M | 45.1M | 25M | 97.33M | 47.7M | 90.3M | 40M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 15.99K | 37.29K | 62K | -131K | -46.67K | 30.89K | -11.7K | 125K | 12K | 67K | n/a | n/a |
Investing Cash Flow | 25.32M | -100.23M | -30.9M | 37.75M | -61.16M | 9.85M | 14.3M | 35.63M | 18.55M | 20.33M | -53.94M | 29.49M | -14.25M | -180.52M | -3.05M | -1.69M | -2.7M | -2.22M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 231K | n/a | n/a | -231K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 47.61M | 656K | n/a | n/a | n/a | n/a | 1.2M | 18K | 379K | -217K | 96K | 153K | -135K | -1.55M | 205.47M | -231K |
Financial Cash Flow | 365K | 14K | 608K | 15K | 98.02M | 246K | 25.17M | 1.1M | 1.2M | 18K | 20.43M | -217K | 96K | 153K | -135K | 29.46M | 205.47M | 142.77M |
Net Cash Flow | -9.03M | -145.72M | 98.63M | 16.77M | 9.1M | -28.35M | 69.05M | 12.02M | -5.57M | -3.06M | -57.47M | 8.67M | -34.65M | -207.77M | -17.35M | 9.97M | 189.19M | 126.74M |
Free Cash Flow | -36.41M | -47.08M | 128.74M | -21.39M | -29.79M | -39.55M | 27.95M | -26.36M | -31.84M | -32.59M | -31.23M | -22M | -23.05M | -29.09M | -17.23M | -19.55M | -16.28M | -16.03M |